Pharma Journalist - Page 770 of 923 -

MSD Completes $5.8 Billion Terns Pharmaceuticals Acquisition

Madrigal Licenses Gene Therapy Candidate for MASH Treatment

Citius Oncology Secures $36.5M to Boost LYMPHIR Launch

GlycoMimetics unveils design of Phase 3 Clinical Trial for GMI-1271 in Relapsed AML

FDA approves IND application for Moleac’s Phase 1 study MLC1501

Prometic receives Rare Pediatric Disease Designation from FDA

Vanda Pharmaceutical’s HETLIOZ for symptoms of jet lag disorder

MyBiotics signs second option agreement with Ferring Holding for the validation

Benitec Biopharma initiates Phase 2 Oncology Study in Australia

Trovagene confirms enrollment of First patient for Cycle 1 Treatment with PCM-075